OKYO Pharma (OKYO) announces that Panetta Partners Limited, an entity in which Gabriele Cerrone, Executive Chairman has a beneficial interest, has acquired 82,018 of the Company’s ordinary shares on NASDAQ, bringing his total holding to 10,464,695 shares.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OKYO:
- OKYO Pharma to Present Urcosimod at OIS XV
- OKYO Pharma to Present at BIO-Europe 2025 Highlighting Urcosimod Progress
- OKYO Pharma’s Chairman Increases Stake with New Share Acquisition
- Okyo Pharma chairman acquires 210,000 company shares
- OKYO Pharma Advances Urcosimod Clinical Trials for Neuropathic Corneal Pain